Michael L. Nieder

6.4k citations
88 papers · 3.8k indexed · 2 hit papers · h-index 30
Topics
Hematopoietic Stem Cell Transplantation (24 papers)Acute Lymphoblastic Leukemia research (15 papers)Analytical Chemistry and Chromatography (13 papers)

In The Last Decade

Michael L. Nieder

81 papers receiving 3.7k citations

Hit Papers

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemo...200220262010201820082002100200300400500

Peers

Michael L. Nieder
Comparison fields: 5 of 142
  • Oncology 1.0k
  • Pulmonary and Respiratory Medicine 780
  • Molecular Biology 695
  • Public Health, Environmental and Occupational Health 663
  • Genetics 631
Replace E. A. de Bruijn with:
E. A. de Bruijn Belgium
R. M. Fox Australia
Kim Pettersson Finland
Róbert de Jonge Netherlands
Frederick P. Ognibene United States
James T. Cassidy United States
Chikara Οhyama Japan
Martin Schreiber Austria
Kate McKeage New Zealand
Irwin H. Krakoff United States
Michael L. Nieder relative to E. A. de Bruijn Belgium E. A. de Bruijn's profile →
Citations per field
00.5×4.0×
E. A. de Bruijn · 1×
Citations per year

Countries citing papers authored by Michael L. Nieder

Since Specialization
Citations

This map shows the geographic impact of Michael L. Nieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Nieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Nieder more than expected).

Fields of papers citing papers by Michael L. Nieder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Nieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Nieder. The network helps show where Michael L. Nieder may publish in the future.

Co-authorship network of co-authors of Michael L. Nieder

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Nieder. A scholar is included among the top collaborators of Michael L. Nieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Nieder. Michael L. Nieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 15
4 9
5 8
6 114
7 95
8 24
9 19
10 50
11
Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Groupbreakdown →
520
12 128
13 8
14 14
15
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)breakdown →
508
16 107
17 39
18 317
19 25
20 36

About Michael L. Nieder

Michael L. Nieder is a scholar working on Hematology, Transplantation and Spectroscopy, having authored 88 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (24 papers), Acute Lymphoblastic Leukemia research (15 papers) and Analytical Chemistry and Chromatography (13 papers). The work is most often cited by research in Genetics (631 citations), Hematology (478 citations) and Oncology (1.0k citations). Michael L. Nieder has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include William Krivit, S L Gerson, John Day, H M Lazarus, Klaus Albert, Ernst Bayer, Lillian Sung, H Jaeger, Mark Krailo and Susan T. Vadaparampil. Their work appears in journals such as JAMA, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026